Michael Steurer

Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.

Idiopathic myelofibrosis with nodal, serosal and parenchymatous infiltration. Case report and review of the literature.

Increase of regulatory T cells in the peripheral blood of cancer patients.

Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha.

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.

Improving tumor cell detection in pleural effusions by interphase cytogenetics.

Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey.

Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.

A new learning paradigm elicits fast visual discrimination in pigeons.

Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia.

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score.

Limits of dynamic object perception in pigeons: dynamic stimulus presentation does not enhance perception and discrimination of complex shape.

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trial.

Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.

Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor.

Visual categorization of natural stimuli by domestic dogs.

The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation.

Inferential reasoning by exclusion in pigeons, dogs, and humans.

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry.

Hodgkin lymphoma in Tyrol-a population-based study.

Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.

GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib.

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.

Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (Rituximab®) for patients with non-Hodkin's Lymphoma: results of a prospective phase I/II study.

Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.

The Multi-Stimulus Box: an innovative learning device for the comparative study of object perception and recognition with various types of stimuli.

[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

The Vienna comparative cognition technology (VCCT): an innovative operant conditioning system for various species and experimental procedures.

Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.

Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantation.

Clinical significance of genetic aberrations in secondary acute myeloid leukemia.

Narrowband UVB therapy for the treatment of pruritus in hypereosinophilic syndrome: clinical report and review of the literature on phototherapy.

Learning of an oddity rule by pigeons in a four-choice touch-screen procedure.

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia.

Diagnostic and therapeutic challenges of a large pleural inflammatory myofibroblastic tumor.

Complement factor H-derived short consensus repeat 18-20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells.

Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.

Transition of idiopathic CD4 + lymphocytopenia into mycosis fungoides?

Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2.

Essential thrombocytemia progressing to Ph+ chronic myeloid leukemia with megakaryoblastic blasts, following anagrelide withdrawal.

Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature.

Ovarian hyperstimulation syndrome in systemic amyloidosis.

Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.

Paraneoplastic phenomena and diagnostic challenges in angioimmunoblastic T-cell lymphoma (AITL): report of two cases and review of the literature.

First experience with brentuximab vedotin in posttransplant lymphoproliferative disorder after liver transplantation: complete remission followed by lethal sepsis.

Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.

Touchscreen performance and knowledge transfer in the red-footed tortoise (Chelonoidis carbonaria).

Discrimination of holograms and real objects by pigeons (Columba livia) and humans (Homo sapiens).

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.

Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivo.

Anagrelide treatment and cardiovascular monitoring in essential thrombocythemia. A prospective observational study.

Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity.

Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study.

Iron metabolism and iron supplementation in cancer patients.

Constitutive Activity among Orphan Class-A G Protein Coupled Receptors.

Obinutuzumab in multidrug-resistant hairy cell leukemia.

Erratum to: Iron metabolism and iron supplementation in cancer patients.

Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia.

Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.

BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.

Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.

Successful immune tolerance induction using turoctocog alfa in an adult haemophilia A patient.

Successful management of mixed chimerism after bone marrow transplant in beta-thalassemia major.

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.

Prevalence of calreticulin exon 9 indel mutations in vascular risk patients.

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option.

Platelet gel: a new therapeutic tool with great potential.

A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.

Ibrutinib for relapsed refractory hairy cell leukemia variant.

Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia.

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.